BetterLife Closes $6.325 Million Bought Deal Public Offering of Units, Including Full Exercise of the Over-Allotment Option
28 mai 2021 09h50 HE
|
BetterLife Pharma Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 28, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the...
BetterLife Announces Closing of a Non-Brokered Private Placement
14 mai 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, May 14, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has closed...
BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs
29 avr. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor
08 avr. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotechnology company...